Co-Diagnostics, Inc. (LON:0A50)
London · Delayed Price · Currency is GBP · Price in USD 5.72
0.00 (0.00%)
At close: Jan 6, 2026
Co-Diagnostics Market Cap
Co-Diagnostics has a market cap or net worth of 8.57 million as of January 6, 2026. Its market cap has decreased by -55.12% in one year.
Market Cap
8.57M
Enterprise Value
1.18M
Revenue
377.84K
Ranking
n/a
PE Ratio
n/a
Stock Price
5.72
Market Cap Chart
Since July 12, 2017, Co-Diagnostics's market cap has decreased from 53.76M to 8.57M, a decrease of -84.06%. That is a compound annual growth rate of -19.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 8.62M | 13.02% |
| Dec 31, 2025 | 7.63M | -60.12% |
| Dec 31, 2024 | 19.13M | -40.10% |
| Dec 29, 2023 | 31.93M | -50.62% |
| Dec 30, 2022 | 64.66M | -66.38% |
| Dec 31, 2021 | 192.31M | -0.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 12, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 207.55B |
| HSBC Holdings | 206.99B |
| Shell | 156.59B |
| Unilever | 104.05B |
| Rio Tinto Group | 103.95B |
| Rolls-Royce Holdings | 103.08B |
| British American Tobacco p.l.c. | 88.35B |
| GSK plc | 73.04B |